Complement-dependent synergistic effects of rat monoclonal IgG antibodies in vivo.
We describe studies aimed at maximizing the effector mechanisms responsible for eliminating target erythrocytes from the circulation in a fully homologous opsonization system in vivo. The effects on the subsequent fate of target erythrocytes were examined in both normal and decomplemented rats preinjected with a variety of rat IgG monoclonal antibodies (mAb) directed against different epitopes on the RT1Aa, the classical class I major histocompatibiliy complex antigen of the DA rat. In general, the clearance of both DA and (DA x PVG)F1 erythrocytes in normal rats preinjected with various pairs of noncompetitive mAb was very rapid when compared with the overall clearance patterns seen with individual antibodies. With all mAb combinations containing IgG2b or IgG2a, an intact complement system was an essential requirement for augmenting the initial clearance and promoting hepatic sequestration of these target cells. The removal of (DA x PVG)F1 erythrocytes, expressing half as much antigen, was considerably slower than the DA cells for each antibody pair tested although a notable degree of heterogeneity was observed in the overall behavior of both types of target cells with different mAb combinations. Our results suggest that the limiting effects of low antigen density on the target cells combined with the use of mAb of an isotype like the rat IgG2a can be overcome using pairs of mAb that recognize different epitopes on the same target antigen.
Yousaf
N
N
Department of Rheumatology, University of Wales College of Medicine, Cardiff.
Howard
J C
JC
Williams
B D
BD
D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology*; D003169:Complement Inactivator Proteins / Q000276:immunology; D003165:Complement System Proteins / Q000276:immunology*; D000939:Epitopes / Q000276:immunology; D004912:Erythrocytes / Q000276:immunology; D015395:Histocompatibility Antigens Class I / Q000276:immunology; D007074:Immunoglobulin G / Q000276:immunology*; D007132:Immunoglobulin Isotypes / Q000276:immunology; D007167:Immunotherapy; D008099:Liver / Q000276:immunology; D008297:Male; D009895:Opsonin Proteins / Q000276:immunology; D051381:Rats; D013154:Spleen / Q000276:immunology
D000911:Antibodies, Monoclonal; D003169:Complement Inactivator Proteins; D000939:Epitopes; D015395:Histocompatibility Antigens Class I; D007074:Immunoglobulin G; D007132:Immunoglobulin Isotypes; D009895:Opsonin Proteins; D003165:Complement System Proteins